6 completed, 4 terminated, 1 recruiting, 1 unknown. 12 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 6, Terminated 4, Recruiting 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Hemorrhagic Stroke: new trials by email Literature Review of Hemorrhagic Stroke trials Research Report on Hemorrhagic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Minocycline in Stroke Study at Maimonides Minocycline 200mg - Stroke, Ischemia Stroke | Phase 2 / Phase 3 | Recruiting | Joyce Chen | 1164 | 2026-02-02 | 2026-03-19 |
| Maimonides Minocycline in Stroke Study Minocycline - Stroke, Acute, Ischemic Stroke | Phase 2 / Phase 3 | Terminated | Maimonides Medical Center | 2 | 2023-11-01 | 2025-12-17 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) Propranolol Hydrochloride, control group - Stroke, Vascular Accident | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 168 | 2023-02-21 | 2025-07-14 |
| Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction GNR-060, Metalyse - ST Elevation Myocardial Infarction | Phase 3 | Completed | AO GENERIUM | 244 | 2021-09-03 | 2026-09-21 |
| Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg, Placebo oral capsule - Cognitive Decline, Intracerebral Hemorrhage | Phase 3 | Terminated | The George Institute | 1 | 2020-02-27 | 2021-04-01 |
| Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome Apolipoprotein A-I [human] (apoA-I), Placebo - Acute Coronary Syndrome | Phase 3 | Completed | CSL Behring | 18226 | 2018-03-21 | 2025-01-14 |
| Rivaroxaban vs. Warfarin in CVT Treatment Rivaroxaban, Warfarin - Cerebral Vein Thrombosis | Phase 3 | Completed | Damascus University | 71 | 2017-09-01 | 2023-02-16 |
| Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial Tranexamic Acid - Stroke Hemorrhagic, Intracerebral Haemorrhage | Phase 3 | Unknown | Kwong Wah Hospital | 220 | 2017-04-01 | 2019-10-17 |
| Field Randomization of Nerinetide (NA-1) Therapy in Early Responders Nerinetide (NA-1), Placebo - Acute Cerebral Ischemia | Phase 3 | Completed | NoNO Inc. | 532 | 2015-03-26 | 2023-05-12 |
| Effectiveness Study on a Virtual Reality Based Training System for Stroke Patients YouGrabber training device from YouRehab Ltd., Therapy (PT, OT) - Cerebrovascular Accident, Hemorrhagic Stroke | Phase 3 | Completed | Reha Rheinfelden | 54 | 2013-01-01 | 2016-04-07 |
| PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients Enoxaparin, Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization - Hemorrhagic Stroke, Venous Thromboembolism | Phase 3 | Terminated | University Of Perugia | 73 | 2012-05-01 | 2021-09-10 |
| Light Constraint Induced Therapy Experiment Light constraint induced therapy, Standard constraint induced therapy - Stroke | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 34 | 2009-02-01 | 2012-01-10 |
Stroke (8) · Cerebral Hemorrhage (4) · Ischemic Stroke (4) · Hypertension (2) · Intracranial Hemorrhages (2) · cyclopia sequence (2) · Acute Coronary Syndrome (1) · Atherosclerosis (1) · Atrial Fibrillation (1) · Cardiovascular Diseases (1) · Cerebral Small Vessel Diseases (1) · Cognitive Dysfunction (1) · Coronary Artery Disease (1) · Coronary Thrombosis (1)
Brain Diseases (12) · Central Nervous System Diseases (12) · Cerebrovascular Disorders (12) · Nervous System Diseases (12) · Vascular Diseases (12) · Cardiovascular Diseases (11) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Hemorrhage (5) · Stroke (4) · Embolism and Thrombosis (3) · Intracranial Hemorrhages (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Coronary Disease (2)
Minocycline (2) · Amlodipine (1) · Apolipoprotein A-I (1) · CSL112 (1) · Constraint Induced Movement Therapy (1) · Control Groups (1) · Enoxaparin (1) · Indapamide (1) · Propranolol (1) · Rivaroxaban (1) · Telmisartan (1) · Tenecteplase (1) · Therapeutics (1) · Tranexamic Acid (1) · Tranylcypromine (1)
AO GENERIUM (1) · Assistance Publique - Hôpitaux de Paris (1) · Beijing Tiantan Hospital (1) · CSL Behring (1) · Damascus University (1) · Joyce Chen (1) · Kwong Wah Hospital (1) · Maimonides Medical Center (1) · NoNO Inc. (1) · Reha Rheinfelden (1) · The George Institute (1) · University Of Perugia (1)
United States (3) · Australia (2) · Canada (2) · France (2) · Hong Kong (2) · Italy (2) · Netherlands (2) · Russia (2) · Switzerland (2) · Argentina (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Chile (1)
Daniel Kiper, PD PhD (1) · Danielle Duffy, MD (1) · Jim Christenson, M.D. (1) · Oksana A. Markova, MD, MSc (1) · Peter YM Woo, FRCS (1) · Prof Craig Anderson (1) · Prof Sharon Naismith (1) · Qingliang T. Wang, MD, PhD (1) · Richard Swartz, M.D. (1)
PMID 25194928, PMID 30356229, PMID 33190135, PMID 36700520, PMID 37548010, PMID 37870112, PMID 39221651, PMID 39230545, PMID 39955120, PMID 40376280
2017 (1)